NeueHealth (NEUE) Competitors

James River Group (NASDAQ:JRVR) and NeueHealth (NYSE:NEUE) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, community ranking and risk.

Do insiders & institutionals believe in JRVR or NEUE?

95.2% of James River Group shares are held by institutional investors. Comparatively, 63.9% of NeueHealth shares are held by institutional investors. 16.5% of James River Group shares are held by insiders. Comparatively, 64.3% of NeueHealth shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Do analysts rate JRVR or NEUE?

James River Group presently has a consensus price target of $6.06, suggesting a potential upside of 40.99%. NeueHealth has a consensus price target of $7.00, suggesting a potential upside of 7.36%. Given James River Group's stronger consensus rating and higher possible upside, research analysts plainly believe James River Group is more favorable than NeueHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
James River Group	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
NeueHealth	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more risk and volatility, JRVR or NEUE?

James River Group has a beta of 0.04, suggesting that its stock price is 96% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500.

Is JRVR or NEUE more profitable?

James River Group has a net margin of -20.84% compared to NeueHealth's net margin of -36.28%. James River Group's return on equity of 3.90% beat NeueHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
James River Group	-20.84%	3.90%	0.41%
NeueHealth	-36.28%	-6.40%	8.45%

Does the MarketBeat Community prefer JRVR or NEUE?

James River Group received 352 more outperform votes than NeueHealth when rated by MarketBeat users. Likewise, 64.00% of users gave James River Group an outperform vote while only 0.00% of users gave NeueHealth an outperform vote.

Company	Underperform	Outperform
James River Group	Outperform Votes 352 64.00%	Underperform Votes 198 36.00%
NeueHealth	Outperform Votes No Votes	Underperform Votes 2 100.00%

Which has higher valuation & earnings, JRVR or NEUE?

James River Group has higher earnings, but lower revenue than NeueHealth. James River Group is trading at a lower price-to-earnings ratio than NeueHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
James River Group	$707.63M	0.28	-$107.68M	-$2.90	-1.48
NeueHealth	$936.66M	0.06	-$1.15B	-$22.63	-0.29

Does the media favor JRVR or NEUE?

In the previous week, James River Group and James River Group both had 2 articles in the media. James River Group's average media sentiment score of 0.97 beat NeueHealth's score of 0.00 indicating that James River Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
James River Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeueHealth	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

James River Group beats NeueHealth on 12 of the 17 factors compared between the two stocks.